Status:
COMPLETED
Tobacco Use and COVID-19 Incidence in the Finnish General Population
Lead Sponsor:
Finnish Institute for Health and Welfare
Collaborating Sponsors:
Karolinska Institutet
Norwegian Institute of Public Health
Conditions:
SARS-CoV-2 Infection
Covid19
Eligibility:
All Genders
20+ years
Brief Summary
This is an observational study of participants in three general population health surveys (FinSote 2018, 2019, 2020) who are followed up until the incidence of SARS-CoV-2 infection or end of follow-up...
Detailed Description
Tobacco use, as a leading risk factor of death and disability due to respiratory diseases, was expected to increase the risk of SARS-CoV-2 infection and COVID-19 deaths. Earlier epidemiological studie...
Eligibility Criteria
Inclusion
- Permanent residents of Finland
- Registered in the Population Register at the moment of sampling
- Aged 20 and over
- Participated in the FinSote surveys in 2018, 2019 or 2020
Exclusion
- Temporary residents in Finland or tourists
- Age less than 20 years old
- Did not participate in FinSote surveys in 2018, 2019 and 2020
Key Trial Info
Start Date :
October 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
60872 Patients enrolled
Trial Details
Trial ID
NCT04915781
Start Date
October 2 2017
End Date
December 30 2021
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Finland
Helsinki, Finland, 00271